Topic: artificial intelligence
Digital pathology startup Paige.AI has received a breakthrough device designation from the FDA for its use of AI in the diagnosis of cancer.
Todd Usen has taken the helm of a Boston-based startup developing a surgical robot that can autonomously suture soft tissue.
Day Zero Diagnostics raised $8.6 million in series A to rapidly profile the antibiotic resistance of infectious diseases using genomic sequencing.
Merck KGaA and Tencent will work to develop AI-based platforms to help increase access to healthcare services and promote disease awareness.
As Brexit approaches, the U.K. plans to invest £100 million to attract 1,000 Ph.D.s focused on artificial intelligence, including in the life sciences.
Charles River teams with Atomwise in an effort to streamline research efforts to speed drugs to market.
GE Healthcare and Vanderbilt University are developing diagnostics that use AI to predict both efficacy and side effects of cancer immunotherapies.
We certainly like to offer a full breakfast here at FierceBiotech, especially at the J.P. Morgan Healthcare Conference here in San Francisco.
Sophia Genetics raised $77 million in new venture capital to help fund its expansion to its new U.S. location and bring on more staff.
Owkin has unveiled what it calls the world’s largest network for artificial intelligence-based medical research, with data from over 40 institutions.